Clinical Trials on Old Age; Dementia in Japan

Total 181 results

Tokyo University
Google LLC.

Enrolling by invitation

Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults (INSPIOR)

Cognitive Function | MCI | Cognition Disorders in Old Age | Frailty/Sarcopenia

Japan
Mie University

Unknown

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Exudative Age-related Macular Degeneration

Japan
Kyowa Kirin Co., Ltd.

Terminated

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Healthy Volunteers | Wet Age-related Macular Degeneration

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.

Neovascular Age-related Macular Degeneration

Japan
Fuji Yakuhin Co., Ltd.

Completed

Study of FFI-1010 in Pediatric Kidney Disease

Children Under 18 Years Old With Kidney Disease

Japan
Kumamoto University

Completed

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Age-related Macular Degeneration

Japan
Sakakibara Heart Institute
CellBank of Japan

Unknown

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration (JOKER)

Chronic Heart Failure | Old Myocardial Infarction

Japan
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Exploratory Study for the Validity of QuQu Scale (QuQu)

Alzheimer Dementia

Japan
AstraZeneca

Completed

A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years

Healthy Japanese Children Age 2 Years Through 6 Years

Japan
Nihon University

Completed

Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration

Age-related Macular Degeneration

Japan
Novartis

Completed

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)

Japan
Osaka University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Age Related Macular Degeneration | Neovascular Maculopathy

Japan
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Verification Study and Reactivity Study for the Validity of QuQu Scale (QuQu)

Alzheimer's Disease Dementia | Cognitive Concern Without Dementia

Japan
Ophthalmic PDT Study Group

Completed

PDT Study for Exudative AMD With PCV

Age Related Macular Degeneration

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Novo Nordisk A/S

Completed

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

Foetal Growth Problem | Small for Gestational Age

Japan
Mirai Iryo Research Center, Inc.

Completed

Intensive Instruction on the Use of Aricept

Alzheimer's Type Dementia

Japan
Osaka University

Completed

Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies (DLB)

Japan
Otsuka Pharmaceutical Co., Ltd.

Terminated

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Janssen Pharmaceutical K.K.

Completed

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Lewy Body Disease | Dementia, Lewy Body

Japan
Astellas Pharma Inc
Ono Pharmaceutical Co. Ltd

Completed

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

Osteoporosis | Bone Loss, Age-Related

Japan
National Cerebral and Cardiovascular Center, Japan

Completed

Adrenomedullin for CADASIL (AMCAD)

Cadasil

Japan
Novo Nordisk A/S

Completed

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Foetal Growth Problem | Small for Gestational Age

Japan
University of Jazan

Completed

Effectiveness Of Computer-Based Cognitive Training in Age-Related Cognitive Decline

Age-related Cognitive Decline

Saudi Arabia
Heptares Therapeutics Limited
Sosei

Withdrawn

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies

Japan
Kyushu University
Novartis; Kurume University; Fukuoka University; University of Occupational and... and other collaborators

Unknown

Ranibizumab Treatment for Age-Related Macular Degeneretion (QUATRO)

Visual Disorder Due to Age-related Macula Degeneration

Japan
Bayer

Recruiting

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Visual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)

Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
Kringle Pharma, Inc.

Recruiting

Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar

Vocal Fold Scar

Japan
Osaka City University

Unknown

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Alzheimer's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

Alzheimer Disease

Japan
Avid Radiopharmaceuticals

Withdrawn

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

Alzheimer's Disease

Japan
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

Alzheimer Disease

Japan
Meiji Gakuin University

Recruiting

Group-based Acceptance and Commitment Therapy for Family Caregivers of People With Dementia in Japan

Dementia | Family Caregivers

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-4666

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Healthy | Alzheimer Disease

Japan
Showa Inan General Hospital

Completed

The Effectiveness of an Exclusive Cold Snare Polypectomy Snare for the Removal of Diminutive Colorectal Polyps

Postpolypectomy Bleeding | Diminutive Colorectal Polyp | Cold Snare Polypectomy | Polypectomy Snare | Complete Resection Rate

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Alzheimer's Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males

Alzheimer Disease

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Alzheimer's Desease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.

Alzheimer's Disease

Japan
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
National Center of Neurology and Psychiatry, Japan

Terminated

Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research (ADAPT)

Depression | Alzheimer Disease

Japan
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Alzheimer Disease

Japan

3

Subscribe